Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$191,263,537
+$18,817,228 QoQ
Shares Held
753,095
+6.8% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#206
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $928,724,025 across 9 Drug Manufacturers - General names. JNJ ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
257,172 | $308,459,837 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
753,095 | $191,263,537 | |
| 3 | ABBV |
AbbVie Inc.
|
548,411 | $138,002,144 | |
| 4 | MRK |
Merck & Co., Inc.
|
786,562 | $101,073,217 | |
| 5 | AMGN |
Amgen Inc
|
169,380 | $61,335,885 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
321,765 | $40,651,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
690,291 | $39,774,567 | |
| 8 | PFE |
Pfizer Inc
|
1,568,204 | $37,762,352 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $191,263,537 | 753,095 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $172,446,309 | 705,475 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $29,317,571 | 141,665 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $20,516,908 | 110,651 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,072,620 | 26,662 | Shares | Sole | 2025-08-05 | |
| 2024-12-31 | $15,576,730 | 107,708 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $18,373,876 | 113,377 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $22,307,231 | 152,622 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $27,765,825 | 175,522 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $37,484,527 | 239,151 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $61,818,888 | 396,911 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $71,884,011 | 434,292 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $68,682,825 | 443,115 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $77,521,969 | 438,845 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $62,109,308 | 380,199 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $51,479,497 | 290,009 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $51,398,295 | 290,009 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $40,202,989 | 235,009 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $33,657,892 | 208,408 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $32,520,993 | 197,408 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $19,296,004 | 117,408 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $19,736,711 | 125,408 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $11,971,143 | 80,408 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $19,745,577 | 140,408 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $34,671,821 | 264,408 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||